We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,406
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLPH
12651
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$17.1K ﹤0.01%
+42,717
New +$21K
RAIN
12652
CALL
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$17.1K ﹤0.01%
19,800
-17,200
-46% -$18.8K
OGG
12653
CALL
Osisko Gold Group
OGG
$872M
$17.1K ﹤0.01%
5,800
-24,700
-81% -$91.8K
CUE icon
12654
PUT
Cue Biopharma
CUE
$233M
$17K ﹤0.01%
247
+30
+14% +$2.93K
THCH icon
12655
CALL
TH International
THCH
$50.9M
$17K ﹤0.01%
1,880
+1,140
+154% +$13.8K
MBC icon
12656
CALL
MasterBrand
MBC
$1.86B
$17K ﹤0.01%
1,400
-3,800
-73% -$46.6K
MOVE icon
12657
Corvex Inc
MOVE
$324M
$17K ﹤0.01%
141
-287
-67% -$39K
LXFR icon
12658
PUT
Luxfer Holdings
LXFR
$457M
$17K ﹤0.01%
1,300
+800
+160% +$10.1K
MMLP icon
12659
PUT
Martin Midstream Partners
MMLP
$93.9M
$17K ﹤0.01%
+6,100
New +$15.8K
BLFY
12660
DELISTED
Blue Foundry Bancorp
BLFY
$16.9K ﹤0.01%
+2,024
New +$19.2K
ENZ
12661
PUT
DELISTED
Enzo Biochem, Inc.
ENZ
$16.9K ﹤0.01%
12,100
-400
-3% -$603
EPIX
12662
DELISTED
ESSA Pharma
EPIX
$16.9K ﹤0.01%
5,475
-5,408
-50% -$15.6K
EHAB
12663
PUT
DELISTED
Enhabit
EHAB
$16.9K ﹤0.01%
1,500
+200
+15% +$2.52K
RMTI icon
12664
CALL
Rockwell Medical
RMTI
$29.2M
$16.8K ﹤0.01%
810
-960
-54% -$29.2K
SKYH.WS icon
12665
Sky Harbour Group Warrants
SKYH.WS
$11.1M
$16.8K ﹤0.01%
84,180
+17,971
+27% +$4.86K
KMPR icon
12666
PUT
Kemper
KMPR
$1.62B
$16.8K ﹤0.01%
400
-500
-56% -$23.7K
OCG icon
12667
Oriental Culture Holding
OCG
$3.31M
$16.8K ﹤0.01%
7
-5
-42% -$10K
FTCI icon
12668
PUT
FTC Solar
FTCI
$38.7M
$16.8K ﹤0.01%
1,310
-860
-40% -$20.8K
ANIK icon
12669
CALL
Anika Therapeutics
ANIK
$288M
$16.8K ﹤0.01%
900
-36,500
-98% -$757K
NBP
12670
PUT
NovaBridge Biosciences American Depositary Shares
NBP
$227M
$16.8K ﹤0.01%
12,700
+3,500
+38% +$7.69K
HT
12671
PUT
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$16.8K ﹤0.01%
1,700
-10,300
-86% -$78.9K
ENTA icon
12672
PUT
Enanta Pharmaceuticals
ENTA
$383M
$16.8K ﹤0.01%
1,500
+600
+67% +$9.66K
CLPS icon
12673
CLPS Inc
CLPS
$25.8M
$16.7K ﹤0.01%
16,707
-7,400
-31% -$7.75K
SLVP icon
12674
iShares MSCI Global Silver and Metals Miners ETF
SLVP
$968M
$16.7K ﹤0.01%
1,946
-3,343
-63% -$32.1K
RNAC icon
12675
CALL
Cartesian Therapeutics
RNAC
$267M
$16.6K ﹤0.01%
523
-200
-28% -$6.68K

Similar funds

Ken Griffin's Q3 2023 Portfolio in Review

As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
  • Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.